286 related articles for article (PubMed ID: 38675377)
1. Advances in IL-7 Research on Tumour Therapy.
Fu C; Zhang X; Zhang X; Wang D; Han S; Ma Z
Pharmaceuticals (Basel); 2024 Mar; 17(4):. PubMed ID: 38675377
[TBL] [Abstract][Full Text] [Related]
2. The Role of IL-7 and IL-7R in Cancer Pathophysiology and Immunotherapy.
Wang C; Kong L; Kim S; Lee S; Oh S; Jo S; Jang I; Kim TD
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142322
[TBL] [Abstract][Full Text] [Related]
3. IL-7 receptor expression levels do not identify CD8+ memory T lymphocyte precursors following peptide immunization.
Lacombe MH; Hardy MP; Rooney J; Labrecque N
J Immunol; 2005 Oct; 175(7):4400-7. PubMed ID: 16177081
[TBL] [Abstract][Full Text] [Related]
4. The Therapeutic Values of IL-7/IL-7R and the Recombinant Derivatives in Glioma: A Narrative Review.
Hesari M; Attar Z; Soltani-Shirazi S; Keshavarzian O; Taheri R; Tabrizi R; Fouladseresht H
J Interferon Cytokine Res; 2023 Aug; 43(8):319-334. PubMed ID: 37566474
[TBL] [Abstract][Full Text] [Related]
5. IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8 + T-cell tumour infiltration.
Feng WQ; Zhang YC; Xu ZQ; Yu SY; Huo JT; Tuersun A; Zheng MH; Zhao JK; Zong YP; Lu AG
J Transl Med; 2023 May; 21(1):335. PubMed ID: 37211606
[TBL] [Abstract][Full Text] [Related]
6. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
Wilson EB; El-Jawhari JJ; Neilson AL; Hall GD; Melcher AA; Meade JL; Cook GP
PLoS One; 2011; 6(9):e22842. PubMed ID: 21909397
[TBL] [Abstract][Full Text] [Related]
7. IL-7R-Dependent Phosphatidylinositol 3-Kinase Competes with the STAT5 Signal to Modulate T Cell Development and Homeostasis.
Cui G; Shimba A; Ma G; Takahara K; Tani-Ichi S; Zhu Y; Asahi T; Abe A; Miyachi H; Kitano S; Hara T; Yasunaga JI; Suwanai H; Yamada H; Matsuoka M; Ueki K; Yoshikai Y; Ikuta K
J Immunol; 2020 Feb; 204(4):844-857. PubMed ID: 31924648
[TBL] [Abstract][Full Text] [Related]
8. Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells.
Galvin KC; Dyck L; Marshall NA; Stefanska AM; Walsh KP; Moran B; Higgins SC; Dungan LS; Mills KH
Cancer Immunol Immunother; 2013 Jul; 62(7):1273-82. PubMed ID: 23657628
[TBL] [Abstract][Full Text] [Related]
9. Saga of monokines in shaping tumour-immune microenvironment: Origin to execution.
Challagundla N; Shah D; Yadav S; Agrawal-Rajput R
Cytokine; 2022 Sep; 157():155948. PubMed ID: 35764025
[TBL] [Abstract][Full Text] [Related]
10. Flip the coin: IL-7 and IL-7R in health and disease.
Barata JT; Durum SK; Seddon B
Nat Immunol; 2019 Dec; 20(12):1584-1593. PubMed ID: 31745336
[TBL] [Abstract][Full Text] [Related]
11. Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo.
Vogt A; Sievers E; Lukacs-Kornek V; Decker G; Raskopf E; Meumann N; Büning H; Sauerbruch T; Strassburg CP; Schmidt-Wolf IG; Gonzalez-Carmona MA
Liver Int; 2014 Mar; 34(3):447-61. PubMed ID: 23998316
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
Sugita S; Kawazoe Y; Imai A; Yamada Y; Horie S; Mochizuki M
Arthritis Res Ther; 2012 May; 14(3):R99. PubMed ID: 22546542
[TBL] [Abstract][Full Text] [Related]
13. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy.
Zhou T; Damsky W; Weizman OE; McGeary MK; Hartmann KP; Rosen CE; Fischer S; Jackson R; Flavell RA; Wang J; Sanmamed MF; Bosenberg MW; Ring AM
Nature; 2020 Jul; 583(7817):609-614. PubMed ID: 32581358
[TBL] [Abstract][Full Text] [Related]
14. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
16. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
Coutinho A; Caramalho I; Seixas E; Demengeot J
Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
[TBL] [Abstract][Full Text] [Related]
17. Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6.
Guo D; Chen Y; Wang S; Yu L; Shen Y; Zhong H; Yang Y
Immunology; 2018 May; 154(1):132-143. PubMed ID: 29197065
[TBL] [Abstract][Full Text] [Related]
18. Up for Mischief? IL-17/Th17 in the tumour microenvironment.
Maniati E; Soper R; Hagemann T
Oncogene; 2010 Oct; 29(42):5653-62. PubMed ID: 20729908
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-7 in HIV pathogenesis and therapy.
Chahroudi A; Silvestri G
Eur Cytokine Netw; 2010 Sep; 21(3):202-7. PubMed ID: 20729180
[TBL] [Abstract][Full Text] [Related]
20. IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells.
Kastirr I; Maglie S; Paroni M; Alfen JS; Nizzoli G; Sugliano E; Crosti MC; Moro M; Steckel B; Steinfelder S; Stölzel K; Romagnani C; Botti F; Caprioli F; Pagani M; Abrignani S; Geginat J
J Immunol; 2014 Oct; 193(7):3322-31. PubMed ID: 25172491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
